These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 21326813)
1. D2-40: an additional marker for myoepithelial cells of breast and the precaution in interpreting tumor lymphovascular invasion. Ren S; Abuel-Haija M; Khurana JS; Zhang X Int J Clin Exp Pathol; 2011 Jan; 4(2):175-82. PubMed ID: 21326813 [TBL] [Abstract][Full Text] [Related]
2. D2-40 expression by breast myoepithelium: potential pitfalls in distinguishing intralymphatic carcinoma from in situ carcinoma. Rabban JT; Chen YY Hum Pathol; 2008 Feb; 39(2):175-83. PubMed ID: 18206495 [TBL] [Abstract][Full Text] [Related]
3. Myoepithelial cell differentiation markers in ductal carcinoma in situ progression. Russell TD; Jindal S; Agunbiade S; Gao D; Troxell M; Borges VF; Schedin P Am J Pathol; 2015 Nov; 185(11):3076-89. PubMed ID: 26343330 [TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical distinction of invasive from noninvasive breast lesions: a comparative study of p63 versus calponin and smooth muscle myosin heavy chain. Werling RW; Hwang H; Yaziji H; Gown AM Am J Surg Pathol; 2003 Jan; 27(1):82-90. PubMed ID: 12502930 [TBL] [Abstract][Full Text] [Related]
5. Significance of lymph vessel invasion identified by the endothelial lymphatic marker D2-40 in node negative breast cancer. Arnaout-Alkarain A; Kahn HJ; Narod SA; Sun PA; Marks AN Mod Pathol; 2007 Feb; 20(2):183-91. PubMed ID: 17206106 [TBL] [Abstract][Full Text] [Related]
6. Epithelial displacement into the lymphovascular space can be seen in breast core needle biopsy specimens. Koo JS; Jung WH; Kim H Am J Clin Pathol; 2010 May; 133(5):781-7. PubMed ID: 20395526 [TBL] [Abstract][Full Text] [Related]
7. Loss of myoepithelial calponin-1 characterizes high-risk ductal carcinoma in situ cases, which are further stratified by T cell composition. Mitchell E; Jindal S; Chan T; Narasimhan J; Sivagnanam S; Gray E; Chang YH; Weinmann S; Schedin P Mol Carcinog; 2020 Jul; 59(7):701-712. PubMed ID: 32134153 [TBL] [Abstract][Full Text] [Related]
8. Estrogen Receptor and Cytokeratin 5 Are Reliable Markers to Separate Usual Ductal Hyperplasia From Atypical Ductal Hyperplasia and Low-Grade Ductal Carcinoma In Situ. Martinez AP; Cohen C; Hanley KZ; Li XB Arch Pathol Lab Med; 2016 Jul; 140(7):686-9. PubMed ID: 27116088 [TBL] [Abstract][Full Text] [Related]
9. Distribution of calponin and smooth muscle myosin heavy chain in fine-needle aspiration biopsies of the breast. Dabbs DJ; Gown AM Diagn Cytopathol; 1999 Apr; 20(4):203-7. PubMed ID: 10204102 [TBL] [Abstract][Full Text] [Related]
10. Lymphatic vessel density as prognostic factor in breast carcinoma: relation to clinicopathologic parameters. El-Gendi S; Abdel-Hadi M J Egypt Natl Canc Inst; 2009 Jun; 21(2):139-49. PubMed ID: 21057565 [TBL] [Abstract][Full Text] [Related]
11. Phenotypic alterations in ductal carcinoma in situ-associated myoepithelial cells: biologic and diagnostic implications. Hilson JB; Schnitt SJ; Collins LC Am J Surg Pathol; 2009 Feb; 33(2):227-32. PubMed ID: 18936688 [TBL] [Abstract][Full Text] [Related]
12. Significance of pathological evaluation for lymphatic vessel invasion in invasive breast cancer. Ito M; Moriya T; Ishida T; Usami S; Kasajima A; Sasano H; Ohuchi N Breast Cancer; 2007; 14(4):381-7. PubMed ID: 17986803 [TBL] [Abstract][Full Text] [Related]
13. Attenuated podoplanin staining in breast myoepithelial cells: a potential caveat in the diagnosis of lymphatic invasion. Yang Z; Adams AL; Hameed O Appl Immunohistochem Mol Morphol; 2009 Oct; 17(5):425-30. PubMed ID: 19363443 [TBL] [Abstract][Full Text] [Related]
14. A useful immunohistochemical approach to evaluate intraductal proliferative lesions of the breast and to predict their prognosis. Omi Y; Yamamoto T; Okamoto T; Obara T; Kobayashi M Histol Histopathol; 2011 Jan; 26(1):79-86. PubMed ID: 21117029 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic utility of p75 neurotrophin receptor (p75NTR) as a marker of breast myoepithelial cells. Popnikolov NK; Cavone SM; Schultz PM; Garcia FU Mod Pathol; 2005 Dec; 18(12):1535-41. PubMed ID: 16258511 [TBL] [Abstract][Full Text] [Related]
16. Chalkley microvessel but not lymphatic vessel density correlates with axillary lymph node metastasis in primary breast cancers. Kanngurn S; Thongsuksai P; Chewatanakornkul S Asian Pac J Cancer Prev; 2013; 14(1):583-7. PubMed ID: 23534799 [TBL] [Abstract][Full Text] [Related]
17. Diminished number or complete loss of myoepithelial cells associated with metaplastic and neoplastic apocrine lesions of the breast. Tramm T; Kim JY; Tavassoli FA Am J Surg Pathol; 2011 Feb; 35(2):202-11. PubMed ID: 21263240 [TBL] [Abstract][Full Text] [Related]
18. Loss of MMP-8 in ductal carcinoma in situ (DCIS)-associated myoepithelial cells contributes to tumour promotion through altered adhesive and proteolytic function. Sarper M; Allen MD; Gomm J; Haywood L; Decock J; Thirkettle S; Ustaoglu A; Sarker SJ; Marshall J; Edwards DR; Jones JL Breast Cancer Res; 2017 Mar; 19(1):33. PubMed ID: 28330493 [TBL] [Abstract][Full Text] [Related]
19. [Value of CK5/6, CK14, ER and PR detection in differential diagnosis of intraductal proliferative lesions of the breast]. Niu F; Wang L; Zhang W; Lyu S; Niu Y Zhonghua Zhong Liu Za Zhi; 2015 Oct; 37(10):749-52. PubMed ID: 26813593 [TBL] [Abstract][Full Text] [Related]
20. [Expression of fatty acid synthase and its association with HER2 in invasive ductal carcinoma of breast]. Yang M; Xu SP; Ao QL Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):257-61. PubMed ID: 23928534 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]